Literature DB >> 35796944

Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy.

Yuval Yogev1, Jacob Bistritzer2, Yair Sadaka3,4, Analia Michaelovsky2, Yuval Cavari5, Yael Feinstein5, Munir Abu-Madegem6, Yakov Fellig7, Ohad Wormser1, Max Drabkin1, Daniel Halperin1, Ohad S Birk8,9.   

Abstract

INTRODUCTION: Congenital myopathies are a broad group of inborn muscle disorders caused by a multitude of genetic factors, often characterized by muscle atrophy and hypotonia.
METHODS: Clinical studies, imaging, histology, whole-exome sequencing (WES) and muscle tissue RNA studies.
RESULTS: We describe a severe congenital myopathy manifesting at birth with bilateral clubfeet, delayed motor development and hypotonia, becoming evident by 4 months of age. At 3 years of age, the patient had tongue fasciculations, was bedridden, and was chronically ventilated via tracheostomy. Imaging studies demonstrated severe muscle atrophy and, surprisingly, cerebral atrophy; electromyography demonstrated a myasthenic pattern and histological evaluation did not facilitate a definitive diagnosis. Trio WES did not identify a causative variant, except for a non-canonical intronic TPM3 c.118-12G>A variant of uncertain significance. Transcript analysis of muscle tissue from the patient proved the pathogenicity of this homozygous variant, with a 97% reduction in the muscle-specific TPM3.12 transcript. DISCUSSION: This study broadens the phenotypic spectrum of recessive TPM3 disease, highlighting tongue fasciculations and bilateral clubfoot, as well as possibly-related cerebral atrophy. It also shows the importance of a broad approach to genetic analysis and the utility of RNA-based studies, demonstrating efficacy of early genome and transcriptome queries in facilitating rapid and cost-effective diagnosis of congenital myopathies.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35796944     DOI: 10.1007/s40291-022-00601-6

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.476


  3 in total

1.  Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients.

Authors:  Steven Marston; Massimiliano Memo; Andrew Messer; Maria Papadaki; Kristen Nowak; Elyshia McNamara; Royston Ong; Mohammed El-Mezgueldi; Xiaochuan Li; William Lehman
Journal:  Hum Mol Genet       Date:  2013-07-25       Impact factor: 6.150

2.  A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy.

Authors:  K Kiiski; V-L Lehtokari; A Y Manzur; C Sewry; I Zaharieva; F Muntoni; K Pelin; C Wallgren-Pettersson
Journal:  J Neuromuscul Dis       Date:  2015-09-21

3.  L-Carnitine ameliorates congenital myopathy in a tropomyosin 3 de novo mutation transgenic zebrafish.

Authors:  Po-Jui Hsu; Horng-Dar Wang; Yung-Che Tseng; Shao-Wei Pan; Bonifasius Putera Sampurna; Yuh-Jyh Jong; Chiou-Hwa Yuh
Journal:  J Biomed Sci       Date:  2021-01-12       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.